Perikabiven Injection, Emulsion
Product Images NDC 63323-714

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Perikabiven (NDC 63323-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Per0e 0000 01

The text describes the features and components of a bag used for KabivenUSA infusion. It includes a handle, a hole for hanging, vertical seals that must be broken to activate, bends in the vertical seals, a horizontal seal that may remain unopened, a white additive port, a blue infusion port, and an oxygen absorber. Additionally, it warns against using the blind port and provides a link to an instructional video.*

FDA Label Image

Per0e 0000 02

This text is a set of instructions to be followed when using a Perkabiven 152 three-chambered bag. The bag should be inspected before activation, and if the overpouch is opened, damaged, or the solution is yellow, it should be discarded. The overpouch should be removed by tearing it at the notch, and the long sides should be opened to access the inner bag. The oxygen absorber and the overpouch should be discarded after opening the bag.*

FDA Label Image

Per0e 0000 03

This text provides instructions for activating a bag of contents by breaking both Vertical Seals through continuous pressure and mixing the contents thoroughly. The text also provides information on identifying the correct ports for infusion and additive through the colors of the ports and the direction of the arrows. Furthermore, there are instructions on confirming the activation of the bag through inspecting whether the Vertical Seals are broken and if the contents are entirely white.*

FDA Label Image

Per0e 0000 04

This is a set of instructions for adding prescribed additives to a bag of some substance. The instructions warn to ensure compatibility between additives. The white additive port cap should be broken off and the needle inserted horizontally through the center of the additive port's septum to inject additives. Aseptic technique should be used throughout the process, and the contents should be mixed well after each addition. The septum can be pierced up to 10 times with a needle size 18-23 G 1.5 inches (40mm).*

FDA Label Image

Per0e 0000 05

This text describes instructions for using a spike and hang bag for infusion sets. It advises breaking off the blue infusion port cap before inserting the set, and using a non-vented set or closing the vented set. Using a 1.2 pm in-line filter is recommended. The roller clamp should be closed, and the base of the infusion port should be held while rotating the wrist to insert the spike. The bag should be lifted and held with both hands and hung by the hole below the handle. The infusion port membrane is sterile for first use, and the set recommended has an external spike diameter of 55 to 5.7 mm. The product is for single use only and any unused portion should be discarded.*

FDA Label Image

Per0e 0000 06

FDA Label Image

Per0e 0000 07

FDA Label Image

Per0e 0000 08

FDA Label Image

Per0e 0000 09

FDA Label Image

Per0e 0000 10

FDA Label Image

Per0e 0000 11

FDA Label Image

Per0e 0000 12

FDA Label Image

Per0e 0000 13

FDA Label Image

Per0e 0000 14

FDA Label Image

Per0e 0000 15

FDA Label Image

Per0e 0000 16

FDA Label Image

Per0e 0000 17

FDA Label Image

Per0e 0000 18

FDA Label Image

Per0e 0000 19

FDA Label Image

Per0e 0000 20

FDA Label Image

Per0e 0000 21

FDA Label Image

Per0e 0000 22

FDA Label Image

Per0e 0000 23

FDA Label Image

Per0e 0000 24

This is a description of an intravenous solution, PERIKABIVEN®, containing amino acids, electrolytes, dextrose, and lipid injectable emulsion, with specific percentages of constituents. The bag must be activated by rolling it tightly from the top until the vertical seals break and the contents are white. The total calorie count and product code are given. There are also instructions on dosage and prescribing information. Finally, there is guidance on activating the bag and identifying the additive and infusion ports.*

FDA Label Image

Per0e 0000 25

PERIKABIVEN® 4 x 1440 mL is a sterile, single dose container composed of Amino Acids, Electrolytes, Dextrose, and Lipid Injectable Emulsion. It is for intravenous use (2.4%, 0.5%", 6.8% and 3.5%), and no sulfites are added. It can be used for Peripheral Infusion. It is manufactured by Fresenius Kabi in Uppsala, Sweden. The recommended storage temperature is between 5°C to 25°C (41°F to 77°F) and it should be protected from freezing. Dosage information can be found in the prescribing information. The container also shows batch number 10XX1234, the manufacturing date of 0212022, and use before date of 0172024. For more information, visit www.fresenius-kabi.com/us or call 1-888-386-1300.*

FDA Label Image

Per0e 0000 26

This is a description of a medical product, Perikabiven® by Fresenius Kabi, an Infusion bag from Uppsas, Sweden to be used intravenously. The solution is a combination of Amino Acids, Electrolytes, Dextrose, and Lipid Injectable Emulsion. The bag comes pre-activated and has specific ports for the infusion and additives. The bag must be inspected prior to use to confirm proper activation. The bag can hold up to 1920 mL of the solution and is not compatible with sulfites. The user must follow instructions to ensure proper use.*

FDA Label Image

Per0e 0000 27

PERIKABIVEN® is an intravenous injectable emulsion used to deliver amino acids, electrolytes, dextrose and lipids. It is available in a single-dose container and comes in four volumes of 1920 mL each. The solution doesn't contain any sulphites and is sterile. The emulsion must be administered only by peripheral infusion. The recommended storage temperature is between 5°C to 25°C (41°F to 77°F), and it must be protected from freezing. Manufacturing details include the date of manufacturing, use before date, and the product label where one can find dosage information. Order-related queries must be directed to Customer Service, and the product is manufactured by TR WAL)rossenns KABI.*

FDA Label Image

Per0e 0000 28

This is a description of an intravenous solution, which is a mixture of amino acids, electrolytes, dextrose, and lipid emulsion. It is produced by KABI and comes in four different concentrations. The bag needs to be activated by rolling it tightly until the vertical seals break, which indicates that the contents have been activated. The bag should be inspected before activation. Once activated, the correct ports for additives and infusion should be identified. The solution is suitable for peripheral infusion only. The bag should not be used if it contains more than one crystal, the solution appears yellow, or the seals are already broken. The text provides further information about the contents and dosage instructions.*

FDA Label Image

Per0e 0000 29

PERIKABIVEN® 3 x 2400 mL is a sterile, single-dose container of amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use. It contains 2.4%, 0.5%, 6.8%, and 3.5% of the aforementioned ingredients and does not have sulfites added for peripheral infusion. The recommended storage is between 5°C to 25°C to avoid excessive heat and freezing. The manufacturer's contact details are available for ordering information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.